Contract development and manufacturing capabilities for small molecules, peptide, advanced therapies, and commercial services to help move from molecule to medicine to market.

BBT's end-to-end, integrated CDMO capabilities help biotechnology, pharmaceutical and life sciences companies succeed in drug development and manufacturing. From R&D to regulatory environment support, supply chain management, and all stages in between, our services and solutions cover the entire lifecycle of drug substances and drug products, spanning the entire process from preclinical research to commercial production.